Regular Article
Astrocytes Promote or Impair the Survival and Function of Embryonic Ventral Mesencephalon Co-grafts: Effects of Astrocyte Age and Expression of Recombinant Brain-Derived Neurotrophic Factor

https://doi.org/10.1006/exnr.1997.6483Get rights and content

Abstract

Intrastriatal grafting of dopamine-rich embryonic ventral mesencephalon (VM) is a potential therapeutic treatment for Parkinson's disease. However, it has been suggested that the efficacy of this procedure might be improved by enhancing the survival and/or degree of neurite outgrowth by the grafted VM, since these parameters are currently suboptimal. In the present study, we tested the ability of astrocytes retrovirally transduced to produce recombinant brain-derived neurotrophic factor (BDNF) to enhance the survival and/or function of embryonic VM in the unilateral 6-hydroxydopamine (6-OHDA) lesioned rat, a well-characterized rodent model of Parkinson's disease. In culture, primary astrocytes derived from Postnatal Day 0 (P0) rat striatum and transduced with the BDNF vector increased the survival of Embryonic Day 15 (E15) dopaminergic VM neurons by approximately threefold and reduced the loss of dopaminergic neurons following 6-OHDA treatment by approximately 20%. The cultured astrocytes were then mixed 1:1 with freshly dissociated E15 VM and co-grafted into the dopamine-denervated striatum. Unexpectedly, the control nontransduced astrocytes reduced the survival of dopaminergic neurons by 60% and restricted the pattern of neurite outgrowth by the co-grafted VM, compared to grafts of VM alone at 7 weeks postgrafting. These effects were paralleled by an attenuated rate and degree of behavioral recovery. The detrimental effects of the control astrocytes were partially reversed when the astrocytes were transduced to express BDNF, although dopaminergic neuron survival was still reduced by 30% compared to that within VM-only grafts. To begin to assess whether the detrimental effects of the astrocytes were related to the maturational state of the cultured astrocytes, astrocytes were obtained from E18 striatum and maintained in short-term culture (9 days vs several weeks for P0 cultures) prior to co-grafting with VM. Interestingly, the younger astrocytes did not reduce graft survival and allowed for better graft integration. These results suggest that primary astrocytes maintained in long-term culture are detrimental to embryonic neural grafts, an effect that is not completely overcome by expression of recombinant BDNF, and that astrocyte age may be an important consideration in the use of these cells as CNS gene delivery vehicles.

References (51)

  • S. Murphy et al.

    Synthesis of nitric oxide in CNS glial cells

    Trends Neurosci.

    (1993)
  • C.W. Olanow et al.

    Fetal nigral transplantation as a therapy in Parkinson's disease

    Trends Neurosci.

    (1996)
  • M. Schinstine et al.

    Intracerebral delivery of growth factors: Potential applications of genetically modified fibroblasts

    Prog. Growth Factor Res.

    (1991)
  • D.M. Snow et al.

    Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowthin vitro

    Exp. Neurol.

    (1990)
  • Y. Yoshimoto et al.

    Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease

    Brain Res.

    (1995)
  • D.M. Yurek et al.

    BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons

    Exp. Neurol.

    (1996)
  • M. Abercrombie

    Estimation of nuclear population from microtome sections

    Anat. Rec.

    (1946)
  • K.S. Bankiewicz et al.

    Histological evaluation of graft survival and gene expression in Parkinsonian non-human primates at 4 months after striatal grafting of fibroblasts genetically modified with tyrosine hydroxylase cDNA

    Soc. Neurosci. Abstr.

    (1995)
  • P. Brundin et al.

    Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behaviour, and dopamine release

    Exp. Brain Res.

    (1988)
  • P. Brundin et al.

    Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum

    Functional Neural Transplantation

    (1994)
  • C. Cepko

    Transduction of genes using retrovirus vectors

  • D.L. Feinstein et al.

    Nitric oxide synthase expression in glial cells: Suppression by tyrosine kinase inhibitors

    J. Neurochem.

    (1994)
  • D.M. Frim et al.

    Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions

    NeuroReport

    (1993)
  • E. Galea et al.

    Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures

    Proc. Natl. Acad. Sci. USA

    (1992)
  • D. Giulian et al.

    Interleukin-1 stimulation of astroglia proliferation after brain injury

    Science

    (1985)
  • Cited by (0)

    S. B. DunnettA. Bjorklund, Eds.

    View full text